Table.
Groups | MT (%) | PE (%) | FMD (%) | N |
---|---|---|---|---|
Control conditions | 8 ± 1 | 40 ± 2 | 25 ± 3 | 13 |
+L-NNA (10 μmol/L) | 21 ± 4† | 46 ± 5 | 11 ± 1† | 12 |
+PEG-catalase (50 U/mL) | 15 ± 3† | 43 ± 3 | 16 ± 1† | 12 |
+PEG-catalase (100 U/mL) | 19 ± 7† | 46 ± 3 | 10 ± 2† | 3 |
+BH4 (1 mmol/L) | 16 ± 3† | 42 ± 4 | 28 ± 3 | 11 |
+L-arginine (5 μmol/L) | 12 ± 8 | 49 ± 5 | 24 ± 1 | 6 |
+PTIO (100 μmol/L) | 8 ± 2 | 40 ± 4 | 26 ± 2 | 8 |
+ODQ (1 μmol/L) | 25 ± 12† | 49 ± 4 | 4 ± 2† | 4 |
+DT-3 (25 nmol/L) | 7 ± 2 | 39 ± 6 | 11 ± 1† | 3 |
+BH4+PTIO | 15 ± 4† | 39 ± 7 | 20 ± 4 | 5 |
+BH4+PEG-catalase | 18 ± 5† | 45 ± 5 | 26 ± 3 | 6 |
+BH4+ODQ | 12 ± 5 | 45 ± 4 | 7 ± 2† | 5 |
+BH4+L-NNA | 17 ± 4† | 44 ± 3 | 11 ± 2† | 4 |
+BH4+PTIO+PEG-catalase | 21 ± 9† | 47 ± 5 | 9 ± 2† | 5 |
+Pyruvate (3 mmol/L) | 8 ± 2 | 42 ± 3 | 15 ± 2† | 6 |
+DETC (1 mmol/L) | 15 ± 2† | 47 ± 3 | 15 ± 1† | 9 |
+L-NNA+indomethacin (10 μmol/L) | 8 ± 3 | 36 ± 3 | 10 ± 3† | 5 |
+PEG-catalase+PTIO | 7 ± 2 | 39 ± 4 | 14 ± 3† | 4 |
+Triciribine (1 μmol/L) | 11 ± 3 | 45 ± 5 | 3 ± 1† | 4 |
+Apocynin (10 μmol/L) | 12 ± 5 | 45 ± 4 | 33 ± 4 | 4 |
−Endothelium | 12 ± 5 | 39 ± 9 | 6 ± 1† | 5 |
Note: Data are expressed as mean±SEM.
MT, PE, and FMD are expressed as the percentage of the maximal diameter.
P<0.05 compared with control conditions.